CMS TEAM Model and the Air We Breathe in the OR: Why Surgical Air Disinfection Matters for SSI Reduction

The Centers for Medicare & Medicaid Services’ Transforming Episode Accountability Model (TEAM) reframes how hospitals are held accountable for surgical outcomes. By tying episode-level quality and cost to performance across the 30-day surgical episode, TEAM puts renewed emphasis on preventing complications that drive readmissions, emergency visits, and overall cost — especially surgical site infections (SSIs). For perioperative teams, this is both a challenge and an opportunity: TEAM rewards systems that prevent harm across the continuum of care. One practical, evidence-informed lever worth integrating into TEAM-focused bundles is continuous surgical air disinfection — an adjunctive strategy that reduces airborne microbial burden, supports established SSI prevention bundles, and helps hospitals meet episode expectations.

TEAM’s episode-based approach changes focus from isolated intraoperative metrics to the entire perioperative pathway. SSI prevention is central to that pathway because SSIs drive morbidity, prolonged recovery, readmissions, and downstream costs — all metrics visible in TEAM reporting. As hospitals prepare for TEAM, infection preventionists, perioperative nurses, surgeons, and value analysis leaders must expand prevention thinking beyond antibiotics and sterile technique to include environmental and engineering controls that reduce exposure to infectious hazards during and immediately after operations.

SSIs result from a complex interplay of host factors, organism virulence, and exposure risk during surgery. While many SSIs arise from endogenous sources (patient flora), a meaningful portion is attributable to exogenous contamination introduced via instruments, implants, personnel, and the environment. Airborne contamination — particularly in long procedures, orthopedic and implant surgeries, or in cases with breaks in sterile technique — can deposit contaminants onto surgical fields and devices. Operating room ventilation, door openings, staff traffic, and localized sources of particulate matter can all elevate airborne microbial load at zones of clinical risk.

Continuous surgical air disinfection technologies aim to reduce viable airborne microorganisms and particulate burden in the operative zone. These systems complement central HVAC and positive-pressure suites by providing localized, persistent reduction of airborne bioburden during the critical intraoperative period — when an implant or open cavity is most vulnerable. Importantly, air disinfection is an adjunct, not a replacement, for established SSI prevention practices. When integrated with antibiotic prophylaxis timing, normothermia, glycemic control, proper skin antisepsis, and sterile technique, enhanced air management can further lower the probability of contamination that leads to SSI.

Controlled studies and meta-analyses in select surgical disciplines have suggested that reducing airborne contamination correlates with lower implant contamination rates and, in some series, lower SSI rates — notably in orthopedic arthroplasty where deep infections carry high clinical and financial impact. However, SSI prevention is multifactorial; air disinfection is unlikely to move outcomes alone where other bundle elements are inconsistent. The prudent, evidence-based approach is therefore to evaluate air disinfection as part of a bundle and to measure its incremental impact through well-designed pilots with clear endpoints (i.e.: SSI rates, readmissions within 30 days, and cost metrics relevant to TEAM).

Operationalizing air disinfection in a TEAM model world include: 

1. Start with risk stratification. Prioritize TEAM-tracked procedures and high-risk cases (e.g., LEJR, spinal fusion, bowel, CABG) where implant presence or patient risk factors make SSI consequences severe.
2. Pilot with clear protocols. Use a standardized pilot protocol that defines device placement (footprint and proximity to field), run time (pre-case and continuous intraoperative), device maintenance, competency training, and objective measures. Predefine safety stop rules and reporting pathways.
3. Bundle integration. Ensure air disinfection is integrated into checklists and the perioperative pathway — from pre-op antibiotic timing and warming to PACU handoffs — not treated as a standalone “fix.”
4. Measure what matters to TEAM. Track process and outcome metrics that TEAM values: 30-day readmission rates related to SSIs, ED visits, implant revision rates (if relevant), as well as process fidelity metrics (bundle adherence, door openings, temperature, glucose control). Collect baseline data, measure during the pilot, and compare with matched controls where feasible.
5. Engage multidisciplinary stakeholders. Value analysis, IP, periop nursing, anesthesia, biomedical engineering, and supply chain must co-lead procurement decisions, IFU adherence, and staff training. Early surgeon and anesthesia engagement is critical for uptake.
6. Document ROI and narratives. TEAM will reward demonstrable reductions in complications and costs. Build an evidence pack (clinical outcomes + economic model) to inform scaling decisions and to support discussions with executive leadership and payors.

Practical implementation tips to Improve Sustainable Success: 

• Use human factors-informed placement and usability testing before a full pilot to minimize workflow disruption.
• Verify compatibility with other OR equipment and cleaning protocols; follow manufacturer IFUs for cleaning/maintenance to preserve efficacy and safety.
• Train proctors and clinical champions to model correct setup and troubleshooting.
• Include communication scripts for patient and family education (explain adjunctive air controls as part of a comprehensive SSI prevention plan).

Under the TEAM model, continuous improvement and data transparency are essential. Air disinfection pilots should be evaluated with run charts and statistical process control to detect sustained improvement. When pilots show benefit, scale thoughtfully — prioritize the highest-impact settings first and maintain audit processes to ensure ongoing fidelity.

In the era of the TEAM model, keeping infections out of the 30-day episode window is a strategic organizational priority. Surgical air disinfection represents a sensible, evidence-aligned adjunct to established prevention bundles. Paired with strong process control, multidisciplinary ownership, and rigorous measurement, air disinfection can help perioperative teams reduce exogenous contamination risk and strengthen their position under TEAM’s episode accountability. The outcome is not only fewer infections, but better patient recovery, fewer readmissions, and the measurable episode performance that the TEAM model seeks to reward.